The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation

Trial Profile

The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2017

At a glance

  • Drugs Prednisolone (Primary)
  • Indications Arteriovenous fistula
  • Focus Therapeutic Use
  • Acronyms LIPMAT
  • Most Recent Events

    • 13 Mar 2017 Last checked against ClinicalTrials.gov record.
    • 25 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top